[1]孔婧** 周秉舵 汤瑾 何聪 唐义爽 王晓素*** 潘旭娣 刘霞 季晶.清下化瘀方联合西医常规疗法对中重度急性胰腺炎患者内毒素、PCT、IL-6、IL-10的影响[J].现代中医药,2023,(05):063-68.[doi:10.13424/j.cnki.mtcm.2023.05.013]
　KONG JingZHOU Bingtuo TANG Jin HE Cong TANG YishuangWANG Xiaosu PAN Xudi LIU Xia JI Jing.Effect of Qingxia Huayu Formula Combined with ConventionalWestern Medicine Therapy on Endotoxins，PCT，IL-6，and IL-10 in Patients with Moderateto Severe Acute Pancreatitis[J].Modern Traditional Chinese Medicine,2023,(05):063-68.[doi:10.13424/j.cnki.mtcm.2023.05.013]
点击复制

清下化瘀方联合西医常规疗法对中重度急性胰腺炎患者内毒素、PCT、IL-6、IL-10的影响()
分享到：

《现代中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2023年05期
页码:
063-68
栏目:
出版日期:
2023-09-20

文章信息/Info

Title:
Effect of Qingxia Huayu Formula Combined with ConventionalWestern Medicine Therapy on Endotoxins，PCT，IL-6，and IL-10 in Patients with Moderateto Severe Acute Pancreatitis
文章编号:
1672-0571(2023)05-0063-06
作者:
孔婧1; 2** 周秉舵1; 2 汤瑾1; 2 何聪1; 2 唐义爽1 王晓素1; 2*** 潘旭娣1 刘霞1 季晶1
1.上海中医药大学附属岳阳中西医结合医院，上海 200437；
2.上海中医药大学中西医结合消化病研究室，上海 200437
Author(s):
KONG Jing1; 2ZHOU Bingtuo1; 2 TANG Jin1; 2 HE Cong1; 2 TANG Yishuang1WANG Xiaosu1; 2 PAN Xudi1 LIU Xia1 JI Jing1
1.Yueyang Integrated Traditional Chinese and Western Medicine Hospital Affiliated to ShanghaiUniversity of Traditional Chinese Medicine，Shanghai 200437,China；
2.Digestive Disease Research Laboratory of Integrated Traditional Chinese and Western Medicine，Shanghai 200437,China
关键词:
关键词：急性胰腺炎; 清下化瘀方; 内毒素; 降钙素原; 炎症介质
Keywords:
Key words:Acute pancreatitis; Qingxia Huayu formula; Endotoxins; Procalcitonin; Inflammatory mediators
分类号:
R256.39
DOI:
10.13424/j.cnki.mtcm.2023.05.013
文献标志码:
A
摘要:
摘 要：目的 观察清下化瘀方对急性胰腺炎患者内毒素、PCT、IL6、IL10的影响，明确其抗炎效果。方法 将60例MSAP或SAP患者分为治疗组30例，对照组30例，对照组给予西药常规治疗，治疗组在对照组的基础上加服清下化瘀方，两组均治疗7天后，通过内毒素、PCT、细胞因子（如IL6、IL10）等检测指标，以观察临床疗效。结果 与对照组比较，治疗组可显著降低AP患者肠源性内毒素水平、降钙素原水平、IL6水平（P＜0.01），两组对IL10水平影响无明显统计学意义（P＞0.05）。结论 早期联合清下化瘀方鼻饲减轻肠源性内毒素移位，减少炎症介质释放，减轻SIRS，降低MODS发生率。
Abstract:
Abstract：Objective To evaluate the effect of Qingxia Huayu formula on endotoxin，PCT，IL-6，and IL-10 in patients with acute pancreatitis，and to clarify its antiinflammatory effect.Methods Sixty MSAP or SAP patients were divided into a treatment group of 30 cases and a control group of 30 cases.The control group was treated with conventional Western medicine，while the treatment group was supplemented with Qingxia Huayu formula.After 7 days of treatment，both groups were tested for endotoxin，PCT，cytokines (such as IL-6 and IL-10) to observe clinical efficacy.Results Compared with the control group，the treatment group significantly reduced the levels of gut derived endotoxins，procalcitonin，and IL-6 in AP patients (P<0.01)，while the two groups had no statistically significant impact on IL-10 levels (P>0.05).Conclusion Early combination of Qingxia Huayu formula nasal feeding can reduce intestinal endotoxin translocation，reduce the release of inflammatory mediators，alleviate SIRS，and reduce the incidence of MODS.

参考文献/References:

［1］Vege SS,Gardner TB,Chari ST,et al.Low mortality and high morbidity in severe acute pancreatitis without organ failure:a case for revising the Atlanta classification to include “moderately severe acute pancreatitis”［J］.The American Journal of Gastroenterology,2009,104(3):710-715.
［2］中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编辑委员会,《中华消化杂志》编辑委员会.中国急性胰腺炎诊治指南(2019,沈阳)［J］.中华胰腺病杂志,2019,19(5):35-38.
［3］孔婧,王晓素,周秉舵,等.中西医结合疗法治疗急性胰腺炎临床观察［J］.上海中医药杂志,2015,49(12):39-41.
［4］周秉舵,方盛泉,朱生樑,等.清下解胰方鼻饲加灌肠联合西药治疗重症急性胰腺炎临床观察［J］.上海中医药杂志,2015,49(4):44-46.
［5］周秉舵,徐亭亭,孔婧,等.清下解胰方改善重症胰腺炎患者肠屏障功能的临床研究［J］.上海中医药大学学报,2015,29(1):33-36.
［6］王兴鹏,李兆申,袁耀宗,等.中国急性胰腺炎诊治指南(2013,上海)［J］.中国实用内科杂志,2013,33(7):530-535.
［7］Glasbrenner B,Adler G.Pathophysiology of acute pancreatitis［J］.Hepatogastroenterology，1993,40(6):517-21.
［8］Hajnády Z,NagyPénzes M,Demény MA,et al.OGG1 inhibition reduces acinar cell injury in a mouse model of acute pancreatitis［J］.Biomedicines,2022,10(10):2543.
［9］Pandol SJ,Gottlieb RA.Calcium,mitochondria and the initiation of acute pancreatitis［J］.Pancreatology,2022,22(7):838-845.
［10］陈婧华,陈垦,王晖.急性胰腺炎发病机制研究进展［J］.世界华人消化杂志,2009,17(24):2478-2483.
［11］侯俊明,王建华.攻下法在重症急性胰腺炎治疗中的临床作用［J］.现代中医药，2010,30(6):29-30.
［12］Singh N,Sonika U,Moka P,et al.Association of endotoxaemia & gut permeability with complications of acute pancreatitis:Secondary analysis of data［J］.Indian J Med Res，2019,149(6):763-770.
［13］NormanJG,Fink GW,Denham W,et al.Tissuespecific cytokine production during experimental acute pancreatitis.A probable mechanism for distant organ dysfunction［J］.Digestive Diseases and Sciences,1997,42(8):1783-1788.
［14］孔婧,王晓素,姜清宇,等.清下化瘀方对急性胰腺炎胃肠道及免疫功能的保护作用［J］.中国中西医结合消化杂志,2014,22(5):245-248,252.
［15］Riedel S,Melendez JH,An AT,et al.Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department［J］.American Journal of Clinical Pathology,2011,135(2):182-189.
［16］GurdaDuda A,Ku s＇nierzCabala B,Nowak W,et al.Assessment of the prognostic value of certain acutephase proteins and procalcitonin in the prognosis of acute pancreatitis［J］.Pancreas,2008,37(4):449-453.
［17］Bulbuller N.Dogru O,Ayten R,et al.Procalcitonin is a predictive marker for severe acute pancreatitis［J］.Ulus Travma Acil Cerrahi Derg,2006,12(2):115-120.
［18］Kolber W,Dumnicka P,Maraj M,et al.Does the automatic measurement of interleukin 6 allow for prediction of complications during the first 48 h of acute pancreatitis?［J］.International Journal of Molecular Sciences,2018,19(6):1820.
［19］Staubli SM,Oertli D,Nebiker CA.Laboratory markers predicting severity of acute pancreatitis［J］.Critical Reviews in Clinical Laboratory Sciences,2015,52(6):273-283.
［20］Hirano T.IL6 ininflammation,autoimmunity and cancer［J］.International Immunology,2021,33(3):127-148.
［21］Vasseur P,Devaure I,Sellier J,et al.High plasma levels of the proinflammatory cytokine IL-22 and the antiinflammatory cytokines IL-10 and IL1ra in acute pancreatitis［J］.Pancreatology,2014,14(6):465-469.
［22］Tran TH,Rastogi R,Shelke J,et al.Modulation of macrophage functional polarity towards antiinflammatory phenotype with plasmid DNA delivery in CD44 targeting hyaluronic acid nanoparticles［J］.Scientific Reports,2015,5:16632.
［23］Yang XM,Yao LB,Fu XH,et al.Experimental acute pancreatitis models:history,current status,and role in translational research［J］.Frontiers in Physiology,2020,11:614591.
［24］Zhang FH,Sun YH,Fan KL,et al.Protective effects of heme oxygenase-1 against severe acute pancreatitis via inhibition of tumor necrosis factor-α and augmentation of interleukin-10［J］.BMC Gastroenterology,2017,17(1):100.

备注/Memo

备注/Memo:
基金项目：国家自然科学基金委员会青年项目（82004264）；上海市申康医院发展中心中西医临床协作试点建设项目（ZY2018-2020-FWTX-1004）
更新日期/Last Update: 2023-09-22